Trial intelligence / Profile preview

Periostin-guided withdrawal of inhaled corticosteroids in asthma patients

2017-002244-33Phase 4Terminated

Sponsor
Copenhagen University Hospital Hvidovre, Department of Respiratory Medicine
Start
Jun 2017
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of budesonide in asthma (2 arms), sponsored by Copenhagen University Hospital Hvidovre, Department of Respiratory Medicine. Primary endpoint: Asthma Control Questionnaire (ACQ) change. Started Jun 2017; status: terminated.

02

Drugs

budesonide
03

Conditions

asthma

Beyond the preview

Go deeper on 2017-002244-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-002244-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call